Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ)
CNY 5.88
(3.34%)
CNY 5.88
(3.34%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -597.65 Million CNY | 12.83% |
| 2022 | -685.58 Million CNY | 48.73% |
| 2021 | -1.33 Billion CNY | -5.18% |
| 2020 | -1.27 Billion CNY | -57.05% |
| 2019 | -809.52 Million CNY | -48.0% |
| 2018 | -546.95 Million CNY | 3.36% |
| 2017 | -565.99 Million CNY | 15.88% |
| 2016 | -672.82 Million CNY | 20.72% |
| 2015 | -848.67 Million CNY | -7.89% |
| 2014 | -786.63 Million CNY | 3.36% |
| 2013 | -814.01 Million CNY | 3.29% |
| 2012 | -841.68 Million CNY | -5.61% |
| 2011 | -796.96 Million CNY | 4.32% |
| 2010 | -832.91 Million CNY | 6.99% |
| 2009 | -895.55 Million CNY | -8343.22% |
| 2008 | -10.6 Million CNY | 6.24% |
| 2007 | -11.31 Million CNY | -1590.33% |
| 2006 | 759.03 Thousand CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -799.69 Million CNY | -33.8% |
| 2024 Q3 | -1.2 Billion CNY | -254.48% |
| 2024 Q2 | -338.54 Million CNY | 57.67% |
| 2023 FY | -597.65 Million CNY | 12.83% |
| 2023 Q1 | -715.11 Million CNY | -4.31% |
| 2023 Q4 | -597.65 Million CNY | -4.59% |
| 2023 Q3 | -571.45 Million CNY | -0.52% |
| 2023 Q2 | -568.48 Million CNY | 20.5% |
| 2022 Q2 | -1.33 Billion CNY | 0.63% |
| 2022 Q3 | -1.44 Billion CNY | -7.87% |
| 2022 Q4 | -685.58 Million CNY | 52.52% |
| 2022 Q1 | -1.34 Billion CNY | -0.73% |
| 2022 FY | -685.58 Million CNY | 48.73% |
| 2021 FY | -1.33 Billion CNY | -5.18% |
| 2021 Q2 | -1.31 Billion CNY | -3.55% |
| 2021 Q3 | -1.33 Billion CNY | -1.05% |
| 2021 Q4 | -1.33 Billion CNY | -0.38% |
| 2021 Q1 | -1.27 Billion CNY | -0.14% |
| 2020 Q3 | -1.25 Billion CNY | 0.48% |
| 2020 Q1 | -1.21 Billion CNY | -49.89% |
| 2020 Q4 | -1.27 Billion CNY | -1.02% |
| 2020 FY | -1.27 Billion CNY | -57.05% |
| 2020 Q2 | -1.26 Billion CNY | -4.23% |
| 2019 FY | -809.52 Million CNY | -48.0% |
| 2019 Q1 | -899.1 Million CNY | -64.35% |
| 2019 Q4 | -809.52 Million CNY | 14.0% |
| 2019 Q3 | -941.33 Million CNY | -26.33% |
| 2019 Q2 | -745.14 Million CNY | 17.12% |
| 2018 Q2 | -702.95 Million CNY | 1.47% |
| 2018 Q3 | -797.04 Million CNY | -13.39% |
| 2018 FY | -546.95 Million CNY | 3.36% |
| 2018 Q4 | -547.05 Million CNY | 31.36% |
| 2018 Q1 | -713.44 Million CNY | -26.05% |
| 2017 Q4 | -565.99 Million CNY | 10.74% |
| 2017 FY | -565.99 Million CNY | 15.88% |
| 2017 Q3 | -634.1 Million CNY | 15.98% |
| 2017 Q2 | -754.74 Million CNY | -3.51% |
| 2017 Q1 | -729.16 Million CNY | -3.93% |
| 2016 FY | -672.82 Million CNY | 20.72% |
| 2016 Q3 | -835.09 Million CNY | -2.72% |
| 2016 Q2 | -812.98 Million CNY | 18.35% |
| 2016 Q1 | -995.68 Million CNY | -10.34% |
| 2016 Q4 | -701.62 Million CNY | 15.98% |
| 2015 FY | -848.67 Million CNY | -7.89% |
| 2015 Q1 | -876.36 Million CNY | -11.41% |
| 2015 Q4 | -902.39 Million CNY | -12.38% |
| 2015 Q3 | -802.96 Million CNY | -11.61% |
| 2015 Q2 | -719.46 Million CNY | 17.9% |
| 2014 Q3 | -810.36 Million CNY | -9.83% |
| 2014 Q2 | -737.83 Million CNY | 9.3% |
| 2014 FY | -786.63 Million CNY | 3.36% |
| 2014 Q1 | -813.44 Million CNY | 0.07% |
| 2014 Q4 | -786.63 Million CNY | 2.93% |
| 2013 Q2 | -835.85 Million CNY | 3.37% |
| 2013 Q4 | -814.01 Million CNY | 2.15% |
| 2013 FY | -814.01 Million CNY | 3.29% |
| 2013 Q1 | -864.98 Million CNY | -2.77% |
| 2013 Q3 | -831.89 Million CNY | 0.47% |
| 2012 Q3 | -836.24 Million CNY | -8.24% |
| 2012 Q2 | -772.57 Million CNY | 9.71% |
| 2012 Q4 | -841.68 Million CNY | -0.65% |
| 2012 FY | -841.68 Million CNY | -5.61% |
| 2012 Q1 | -855.67 Million CNY | -7.37% |
| 2011 FY | -796.96 Million CNY | 4.32% |
| 2011 Q4 | -796.96 Million CNY | -0.42% |
| 2011 Q3 | -793.65 Million CNY | -4.2% |
| 2011 Q1 | -818.25 Million CNY | 1.76% |
| 2011 Q2 | -761.68 Million CNY | 6.91% |
| 2010 Q4 | -832.91 Million CNY | 2.42% |
| 2010 Q1 | -872.65 Million CNY | 2.56% |
| 2010 Q2 | -845.63 Million CNY | 3.1% |
| 2010 Q3 | -853.57 Million CNY | -0.94% |
| 2010 FY | -832.91 Million CNY | 6.99% |
| 2009 FY | -895.55 Million CNY | -8343.22% |
| 2009 Q4 | -895.55 Million CNY | -1009.55% |
| 2009 Q3 | 98.46 Million CNY | 57.6% |
| 2009 Q2 | 62.47 Million CNY | 0.0% |
| 2008 FY | -10.6 Million CNY | 6.24% |
| 2008 Q4 | -10.6 Million CNY | 0.0% |
| 2007 FY | -11.31 Million CNY | -1590.33% |
| 2006 FY | 759.03 Thousand CNY | 0.0% |